GlassScriptPhysician profile
Daneeka A Woods
NPI 1295050953
$2,750.73
in general payments reported to CMS, 2019-2025
16 companies · $1,788 in 2025
The $1,788 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $335 · 2023: $143 · 2024: $334 · 2025: $1,788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,590 · Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,590.00 |
| Food and Beverage | $674.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,605.21 | 2024-2025 | Ozempic, Rybelsus |
| Viiv Healthcare Company | $315.26 | 2023-2025 | Apretude, Cabenuva |
| Lilly USA, LLC | $181.86 | 2021-2025 | Mounjaro, Kisunla, Trulicity |
| Astrazeneca Pharmaceuticals LP | $122.40 | 2022 | |
| Glaxosmithkline, LLC. | $113.11 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Gilead Sciences, INC. | $67.23 | 2021-2023 | |
| Dexcom, INC. | $66.83 | 2022-2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $48.62 | 2022-2025 | Capvaxive |
| Global Blood Therapeutics, INC. | $41.44 | 2021 | |
| Abbvie INC. | $39.92 | 2022 | |
| Pfizer INC. | $36.67 | 2022-2024 | |
| Exact Sciences Corporation | $31.73 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Phadia US INC. | $31.33 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.22 | 2024 | |
| Mannkind Corporation | $18.16 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daneeka Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.